ArticleJACC. Case reports2025
Multimodality Imaging in Anomalous Aortic Origin of the Coronary Arteries: Lessons From 4 Athlete Cases.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnomalous aortic origin of a coronary artery (AAOCA) is a rare congenital anomaly linked to increased risk of myocardial ischemia and sudden cardiac death, especially among athletes subjected to extreme physiological stress. The diagnostic and therapeutic strategies in highly active individuals remain challenging and represent important knowledge gaps. CASE SUMMARY: We present 4 cases of elite athletes with AAOCA with a variety of characteristics and detail their clinical evaluation, imaging and functional assessment, risk stratification, treatment decisions, and longitudinal follow-up. DISCUSSION: There are limited prospective data regarding the management of AAOCA in athletes. Autopsy studies have identified young age (<35 years), high exercise levels, and myocardial fibrosis as risk factors for sudden cardiac death. Moreover, the European Society of Cardiology on adult congenital heart disease recommends including age, level of exercise, and presence of high-risk anomaly features in risk assessment. This series highlights the complexities of managing AAOCA in athletes, and emphasizes the necessity for multimodality imaging in a context of multidisciplinary, individualized decision-making. TAKE-HOME MESSAGES: A multimodality imaging approach is essential for early recognition, risk stratification, and clinical decision-making in AAOCA. Treatment decisions should be based on symptoms, presence of high-risk features, and inducible ischemia using complementary imaging modalities, with personalized recommendations supported by a multidisciplinary sports cardiology team.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.